Hatfield, PA, United States of America

Laura A Birchenough

This inventor holds 4 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1993-1996.


% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 72(Granted Patents)


Location History:

  • Hatfield, PA (US) (1993)
  • Lansdale, PA (US) (1995)
  • North Wales, PA (US) (1996)

Company Filing History:


Years Active: 1993-1996

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Laura A. Birchenough: Innovator in Fibrinogen Receptor Antagonists

Introduction

Laura A. Birchenough is a prominent inventor based in Hatfield, PA (US). She has made significant contributions to the field of biochemistry, particularly in the development of fibrinogen receptor antagonists. With a total of 4 patents to her name, her work has had a substantial impact on medical research and therapeutic applications.

Latest Patents

Among her latest patents, Laura has focused on fibrinogen receptor antagonists, which are crucial in various medical treatments. These patents include innovative formulas that enhance the efficacy of these antagonists, showcasing her expertise and dedication to advancing medical science.

Career Highlights

Laura A. Birchenough is currently associated with Merck & Co., Inc., a leading global healthcare company. Her role at Merck has allowed her to collaborate with some of the brightest minds in the industry, furthering her research and development efforts.

Collaborations

Throughout her career, Laura has worked alongside notable colleagues such as Melissa S. Egbertson and George D. Hartman. These collaborations have enriched her research and contributed to the success of her innovative projects.

Conclusion

Laura A. Birchenough stands out as a key figure in the development of fibrinogen receptor antagonists, with her work at Merck & Co., Inc. and her impressive patent portfolio. Her contributions continue to influence the field of biochemistry and medical research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…